GENB
Generate Biomedicines, Inc.
Key Financials
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 3 | 3/12/2026 | View on SEC |
| 4 | 3/6/2026 | View on SEC |
| 4 | 3/2/2026 | View on SEC |
| 4 | 3/2/2026 | View on SEC |
| 4 | 3/2/2026 | View on SEC |
| 4 | 3/2/2026 | View on SEC |
| 4 | 3/2/2026 | View on SEC |
| 4 | 3/2/2026 | View on SEC |
| 4 | 3/2/2026 | View on SEC |
| 4 | 3/2/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | GENB |
| Company Name | Generate Biomedicines, Inc. |
| CIK | 2100782 |
| Sector | Pharmaceutical Preparations |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | other |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 888-469-0055 |